These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8361232)

  • 21. A role for the intermediate affinity IL-2R in the protection against glucocorticoid-induced apoptosis.
    Rebollo A; Pitton C; García A; Gómez J; Silva A
    Immunology; 1995 Mar; 84(3):388-95. PubMed ID: 7751021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "In vivo" activated splenic T cells are refractory to interleukin 2 growth "in vitro".
    Bandeira A; Larsson EL; Forni L; Pereira P; Coutinho A
    Eur J Immunol; 1987 Jul; 17(7):901-8. PubMed ID: 3111860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.
    Algeciras-Schimnich A; Griffith TS; Lynch DH; Paya CV
    J Immunol; 1999 May; 162(9):5205-11. PubMed ID: 10227994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 10 protects activated human T lymphocytes against growth factor withdrawal-induced cell death but only anti-fas antibody can prevent activation-induced cell death.
    Pawelec G; Hambrecht A; Rehbein A; Adibzadeh M
    Cytokine; 1996 Dec; 8(12):877-81. PubMed ID: 9050744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activity of recombinant lymphokines on mouse B cell proliferation and cell cycle progression are revealed by 5-bromo-2'-deoxyuridine/Hoechst 33258 dye flow cytometry.
    Seyschab H; Hoehn H; Rabinovitch PS; Chen U
    Eur J Immunol; 1991 Sep; 21(9):2153-60. PubMed ID: 1909644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 4 drives phytohemagglutinin-activated T cells through several cell cycles: no synergism between interleukin 2 and interleukin 4.
    Lehrnbecher T; Merz H; Sebald W; Poot M
    Cytokine; 1991 Nov; 3(6):593-7. PubMed ID: 1724186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vimentin expression is differentially regulated by IL-2 and IL-4 in murine T cells.
    Hornbeck PV; Garrels JI; Capetanaki Y; Heimer S
    J Immunol; 1993 Oct; 151(8):4013-21. PubMed ID: 7691937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
    Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
    J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice.
    Radvanyi LG; Raju K; Spaner D; Mills GB; Miller RG
    Cell Immunol; 1998 Jan; 183(1):1-12. PubMed ID: 9578714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire.
    Iwata M; Hanaoka S; Sato K
    Eur J Immunol; 1991 Mar; 21(3):643-8. PubMed ID: 1826261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCR triggering of anergic CD4 T cells in murine AIDS induces apoptosis rather than cytokine synthesis and proliferation.
    Muralidhar G; Koch S; Broome HE; Swain SL
    J Immunol; 1996 Jul; 157(2):625-35. PubMed ID: 8752910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of T cell clones from an athymic mouse.
    Abromson-Leeman SR; Jayaraman S; Dorf ME
    J Immunol; 1990 Apr; 144(7):2451-8. PubMed ID: 1690767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desferoxamine blocks IL 2 receptor expression on human T lymphocytes.
    Carotenuto P; Pontesilli O; Cambier JC; Hayward AR
    J Immunol; 1986 Apr; 136(7):2342-7. PubMed ID: 3005409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naive murine neonatal T cells undergo apoptosis in response to primary stimulation.
    Adkins B; Chun K; Hamilton K; Nassiri M
    J Immunol; 1996 Aug; 157(4):1343-9. PubMed ID: 8759713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative and qualitative signals determine T-cell cycle entry and progression.
    Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
    Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death.
    Radvanyi LG; Mills GB; Miller RG
    J Immunol; 1993 Jun; 150(12):5704-15. PubMed ID: 8515084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.
    Erickson S; Sangfelt O; Castro J; Heyman M; Einhorn S; Grandér D
    Cell Growth Differ; 1999 Aug; 10(8):575-82. PubMed ID: 10470857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells.
    Terada N; Lucas JJ; Gelfand EW
    J Immunol; 1991 Jul; 147(2):698-704. PubMed ID: 1906503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.